OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies: A cross sectional study
Eugenia Abellá, Macedonia Trigueros, Edwards Pradenas, et al.
Life Science Alliance (2022) Vol. 5, Iss. 12, pp. e202201479-e202201479
Open Access | Times Cited: 6
Eugenia Abellá, Macedonia Trigueros, Edwards Pradenas, et al.
Life Science Alliance (2022) Vol. 5, Iss. 12, pp. e202201479-e202201479
Open Access | Times Cited: 6
Showing 6 citing articles:
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Evangelos Terpos, Pellegrino Musto, Monika Engelhardt, et al.
Leukemia (2023) Vol. 37, Iss. 6, pp. 1175-1185
Open Access | Times Cited: 33
Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Hamid Harandi, Parisa Fallahtafti, Amirali Karimi, et al.
BMC Geriatrics (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 675-675
Open Access | Times Cited: 1
Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders
Nathanael R. Fillmore, Jennifer La, Julie Wu, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6767-6770
Open Access | Times Cited: 2
Nathanael R. Fillmore, Jennifer La, Julie Wu, et al.
Blood Advances (2023) Vol. 7, Iss. 21, pp. 6767-6770
Open Access | Times Cited: 2
Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
Nicola Sgherza, Paola Curci, Rita Rizzi, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023011-e2023011
Open Access | Times Cited: 1
Nicola Sgherza, Paola Curci, Rita Rizzi, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2023) Vol. 15, Iss. 1, pp. e2023011-e2023011
Open Access | Times Cited: 1
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
Nicola Sgherza, Daniela Di Gennaro, Paola Curci, et al.
HemaSphere (2022) Vol. 6, Iss. 12, pp. e800-e800
Open Access | Times Cited: 2
Nicola Sgherza, Daniela Di Gennaro, Paola Curci, et al.
HemaSphere (2022) Vol. 6, Iss. 12, pp. e800-e800
Open Access | Times Cited: 2
